Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
9.34
-0.11 (-1.16%)
Nov 22, 2024, 4:00 PM EST - Market closed
Phathom Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 334.68 | 381.39 | 155.39 | 183.26 | 287.5 | 243.77 | Upgrade
|
| Cash & Short-Term Investments | 334.68 | 381.39 | 155.39 | 183.26 | 287.5 | 243.77 | Upgrade
|
| Cash Growth | 56.63% | 145.45% | -15.21% | -36.26% | 17.94% | 27632.08% | Upgrade
|
| Receivables | 21.05 | 1.64 | - | - | - | - | Upgrade
|
| Inventory | 3.11 | 1.21 | - | - | - | - | Upgrade
|
| Prepaid Expenses | 14.98 | 13.19 | 5.13 | 3.27 | 3.87 | 11.84 | Upgrade
|
| Total Current Assets | 373.82 | 397.43 | 160.51 | 186.53 | 291.37 | 255.6 | Upgrade
|
| Property, Plant & Equipment | 2.49 | 3.62 | 3.49 | 2.56 | 3.36 | 1.4 | Upgrade
|
| Other Long-Term Assets | 10.74 | 12.79 | 0.8 | 0.34 | 0.38 | 0.18 | Upgrade
|
| Total Assets | 387.04 | 413.84 | 164.81 | 189.43 | 295.11 | 257.18 | Upgrade
|
| Accounts Payable | 7.13 | 12.6 | 10 | 5.15 | 16.78 | 0.7 | Upgrade
|
| Accrued Expenses | 37.28 | 18.34 | 15.53 | 13.28 | 30.92 | 2.48 | Upgrade
|
| Current Portion of Long-Term Debt | 20.19 | 7.11 | - | - | 7.35 | - | Upgrade
|
| Current Portion of Leases | 0.68 | 0.73 | 0.71 | 0.49 | 0.47 | 0.16 | Upgrade
|
| Other Current Liabilities | - | - | - | - | - | 0.41 | Upgrade
|
| Total Current Liabilities | 65.29 | 38.78 | 26.24 | 18.92 | 55.52 | 3.75 | Upgrade
|
| Long-Term Debt | 498.12 | 437.66 | 204.79 | 89.67 | 39.63 | 22.78 | Upgrade
|
| Long-Term Leases | - | 0.46 | 1.1 | 1.18 | 1.56 | 0.64 | Upgrade
|
| Other Long-Term Liabilities | 10.75 | 9.7 | 7.5 | 7.5 | 4.13 | 2.06 | Upgrade
|
| Total Liabilities | 574.16 | 486.6 | 239.62 | 117.28 | 100.84 | 29.22 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,001 | 855.92 | 652.28 | 601.52 | 579.76 | 484.37 | Upgrade
|
| Retained Earnings | -1,189 | -928.69 | -727.09 | -529.37 | -385.49 | -256.42 | Upgrade
|
| Shareholders' Equity | -187.11 | -72.76 | -74.81 | 72.16 | 194.27 | 227.96 | Upgrade
|
| Total Liabilities & Equity | 387.04 | 413.84 | 164.81 | 189.43 | 295.11 | 257.18 | Upgrade
|
| Total Debt | 518.99 | 445.96 | 206.6 | 91.34 | 49.02 | 23.57 | Upgrade
|
| Net Cash (Debt) | -184.31 | -64.56 | -51.21 | 91.92 | 238.48 | 220.19 | Upgrade
|
| Net Cash Growth | - | - | - | -61.46% | 8.30% | - | Upgrade
|
| Net Cash Per Share | -3.08 | -1.26 | -1.31 | 2.48 | 7.18 | 19.37 | Upgrade
|
| Filing Date Shares Outstanding | 68.38 | 58.48 | 41.72 | 30.57 | 28.57 | 28.96 | Upgrade
|
| Total Common Shares Outstanding | 68.32 | 57.97 | 41.47 | 30.51 | 28.52 | 24.73 | Upgrade
|
| Working Capital | 308.53 | 358.65 | 134.28 | 167.61 | 235.84 | 251.85 | Upgrade
|
| Book Value Per Share | -2.74 | -1.26 | -1.80 | 2.36 | 6.81 | 9.22 | Upgrade
|
| Tangible Book Value | -187.11 | -72.76 | -74.81 | 72.16 | 194.27 | 227.96 | Upgrade
|
| Tangible Book Value Per Share | -2.74 | -1.26 | -1.80 | 2.36 | 6.81 | 9.22 | Upgrade
|
| Machinery | 4.14 | 4.05 | 2.16 | 1.43 | 1.26 | 0.46 | Upgrade
|
| Construction In Progress | - | - | 0.4 | - | - | - | Upgrade
|
| Leasehold Improvements | 0.16 | 0.14 | 0.12 | 0.08 | 0.05 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.